Literature DB >> 16139648

Effects of ICL670 (deferasirox) on cardiac iron concentrations.

George J Kontoghiorghes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16139648     DOI： 10.1016/S0140-6736(05)67205-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  New developments and controversies in iron metabolism and iron chelation therapy.

Authors:  Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2016-03-26

Review 2.  Current status of iron overload and chelation with deferasirox.

Authors:  V P Choudhry; Rahul Naithani
Journal:  Indian J Pediatr       Date:  2007-08       Impact factor: 1.967

3.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.